Ocugen, Inc. (OCGN) stock
OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.76−0.02 (-2.11%)
Close on Nov 17, 2026Market cap $256.61MP/E –Yield –
Ocugen EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Ocugen
Ocugen has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?